Structure-informed immunomodulation: how polysaccharides modulate selected components of the tumour immune microenvironment

Authors: Zeng, Xinyi; Zeng, Xinhua; Huang, Weichang; Li, Sujun

Source journal: Carbohydrate polymers (2026-12-01)

DOI: 10.1016/j.carbpol.2026.125926

Abstract

Polysaccharides from fungi, plants and algae have been adjunctive cancer immunotherapies for decades, yet clinical impact lags the preclinical literature. This review treats them as structure-informed modulators of selected components of the tumour immune microenvironment, not as nonspecific biological response modifiers. We organize the evidence as one causal chain: fine structure influences which pattern-recognition receptor is engaged, receptor engagement shapes a signalling programme, and that programme shapes effector output; most preparations engage more than one receptor, so a response reflects their combined signalling. We advance three arguments. First, immunomodulation can be bidirectional: TLR4-NF-kappaB reportedly drives activating and suppressive outputs depending on structure, dose and tissue context, though suppressive outputs are documented only outside tumour models. Second, the most consequential recent evidence concerns relief of immunosuppression: PD-L1 downregulation, depletion of myeloid-derived suppressor cells, interference with regulatory T cells and the IL-35 axis, and sensitisation to checkpoint blockade. Third, translational failure reflects addressable barriers: batch heterogeneity, absent receptor-specific genetics, and no quantitative structure-activity model. Clinical evidence - two long-approved fungal preparations and one small single-arm trial - establishes feasibility, not efficacy; plant- and algal-derived polysaccharides remain preclinical or clinically preliminary. Conformational analytics, machine-learning-assisted modelling and engineered delivery may address them.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.